Exclusive

Publication

Byline

Location

Clinical Trial: A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905001) titled 'A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer' on Oc... Read More


Clinical Trial: A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904507) titled 'A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation' on Oct. ... Read More


Clinical Trial: Safety of NRICM301 Added to Standard Care in Adults With Acute Ischemic Stroke

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07902934) titled 'Safety of NRICM301 Added to Standard Care in Adults With Acute Ischemic Stroke' on Oct. 21.... Read More


Clinical Trial: Personalized Drug Treatment of Frail Patients: Integrated Care and Real-Time Home Monitoring

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903584) titled 'Personalized Drug Treatment of Frail Patients: Integrated Care and Real-Time Home Monitorin... Read More


Clinical Trial: A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903272) titled 'A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib,... Read More


Clinical Trial: Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07902752) titled 'Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs' on Oct. 22. Brie... Read More


Clinical Trial: Prickly Pear Pulp Powder Along With an Anti-inflammatory Diet in Patients Having Liver Fibrosis

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903103) titled 'Prickly Pear Pulp Powder Along With an Anti-inflammatory Diet in Patients Having Liver Fibr... Read More


Clinical Trial: Comparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal Disorders

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903142) titled 'Comparison of High-Intensity and Conventional Physical Therapy in Musculoskeletal Disorders... Read More


Clinical Trial: Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study.

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904910) titled 'Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the... Read More


Clinical Trial: The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac Arrest

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905482) titled 'The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expirato... Read More